Porcine or human stentless valves for aortic valve replacement? Results of a 10-year comparative study

Journal of Heart Valve Disease

Volumn 12, Issue 4, 2003, Pages 430-435

  Ali, Ayyaz ^b   Lim, Eric ^b   Halstead, James ^b   Ashrafian, Hutan ^b   Ali, Ziad ^b   Khalpey, Zain ^b   Theodorou, Panagiotis ^b   Chamageorgakis, Themis ^b   Kumar, Pankaj ^b   Jackson, Christopher ^a   Pepper, John ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ALLOGRAFT; AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SURGERY; CREATININE BLOOD LEVEL; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HEART VENTRICLE FUNCTION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; STENT; SURGICAL MORTALITY; SURVIVAL RATE; SWINE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE INSUFFICIENCY; BIOLOGICAL MARKERS; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; CREATININE; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0042062291     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. O'Brien MF, Harrocks S, Stafford EG, et al. The homograft aortic valve: A 29-year, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 2001;10:334-344; discussion 335
2. Albertucci M, Wong K, Petrou M, et al. The use of unstented homograft valves for aortic valve reoperations. Review of a twenty-three-year experience. J Thorac Cardiovasc Surg 1994;107:152-161
3. Haydock D, Barratt-Boyes B, Macedo T, Kirklin JW, Blackstone E. Aortic valve replacement for active infectious endocarditis in 108 patients. A comparison of freehand allograft valves with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg 1992;103:130-139
4. Jin XY, Zhang ZM, Gibson DG, Yacoub MH, Pepper JR. Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg 1996;62:683-690
5. Jin XY, Gibson DG, Yacoub MH, Pepper JR. Perioperative assessment of aortic homograft, Toronto stentless valve, and stented valve in the aortic position. Ann Thorac Surg 1995;60:S395-S401
6. Rajappan K, Melina G, Bellenger NG, et al. Evaluation of left ventricular function and mass after Medtronic Freestyle versus homograft aortic root replacement using cardiovascular magnetic resonance. J Heart Valve Dis 2002;11:60-65; discussion 66
7. Melina G, Mitchell A, Amrani M, Khaghani A, Yacoub MH. Transvalvular velocities after full aortic root replacement: Results from a prospective randomized trial between the homograft and the Medtronic Freestyle bioprosthesis. J Heart Valve Dis 2002;11:54-58; discussion 58-59
8. Gross C, Harringer W, Beran H, et al. Aortic valve replacement: Is the stentless xenograft an alternative to the homograft? Midterm results. Ann Thorac Surg 1999;68:919-924
9. Edmunds LH, Jr., Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112:708-711
10. Jin XY, Westaby S. In vivo hemodynamic characteristics of porcine stentless aortic valves. Semin Thorac Cardiovasc Surg 2001;13:67-74
11. Maselli D, Pizio R, Bruno LP, Di Bella I, De Gasperis C. Left ventricular mass reduction after aortic valve replacement: homografts, stentless and stented valves. Ann Thorac Surg 1999;67:966-971
12. Westaby S, Horton M, Jin XY, et al. Survival advantage of stentless aortic bioprostheses. Ann Thorac Surg 2000;70:785-790; discussion 790-791
13. Park SZ, Reardon MJ. Current status of stentless aortic xenografts. Curr Opin Cardiol 2000;15:74-81
14. Lund O, Chandrasekaran V, Grocott-Mason R, et al. Primary aortic valve replacement with allografts over twenty-five years: Valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg 1999;117:77-91
15. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation 2000;101:2497-502
16. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104:2205-2209
17. Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002;40:1723-1730